ISARIC/WHO Clinical Characterisation Protocol for Severe Emerging Infections [COVID-19] [UPH]
Research type
Research Study
Full title
Novel Coronavirus Observational Study
IRAS ID
126600
Contact name
Calum Semple
Contact email
Sponsor organisation
University of Oxford
ISRCTN Number
ISRCTN 66726260
Clinicaltrials.gov Identifier
CPMS 14152, ; ,
Research summary
New infectious agents, such as the SARS coronavirus, new strains of influenza, and HIV, continually appear and require new investigations to understand how the disease works and how it interacts with the person infected. There is an urgent need to conduct coordinated clinical research relating to the COVID-19 outbreak to learn more about the virus and to provide evidence to help decide treatments and to ensure an effective public health response. This study will provide rapid, coordinated clinical investigation of patients with confirmed COVID-19 infection. It will look at how the virus reproduces and is excreted by the body, how the body responds to infection and treatment over time and how the immune system responds. The study has been designed to ensure that as much data as possible is collected and shared rapidly in a format that can be easily added together, tabulated and analysed across many different settings globally. It is designed to be flexible to ensure the best acceptance by health care organisations. [COVID-19 amendment – 24/02/2020]
REC name
South Central - Oxford C Research Ethics Committee
REC reference
13/SC/0149
Date of REC Opinion
2 Mar 2013
REC opinion
Favourable Opinion